Home / Compliance actions / 552719

FDA Warning Letter — Roselawn Marathon

Case 552719 — FEI 3014329564

The FDA took a Warning Letter action against Roselawn Marathon on Apr 12, 2018 (Cincinnati, OH). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Roselawn Marathon
Date
Apr 12, 2018
Fiscal Year
2018
Product Type
Tobacco
Center
CTP
Location
Cincinnati, OH (United States)

Facility

Other compliance actions

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.